Although not used as a DMARD in RA, PMX has been shown to suppress the release of TNFα from activated T cells of RA patients and also ameliorates experimental arthritis in a model of collagen-induced arthritis in rats, thus indicating that PMX exhibits an anti-inflammatory action both ex vivo and in vivo (12, 64). This evidence concerns the gene TNF and rheumatoid arthritis.